Jubilant Ingrevia Q2 FY27: PAT ₹106 Cr & Rev ₹1,300 Cr

Metric	Value
Revenue	₹1,300 Cr
Net Profit (PAT)	₹106 Cr

📢 Key Event
Jubilant Ingrevia reported Q1 FY27 revenue of ₹533 crores, up 25% YoY, with EBITDA at ₹209 crores (+36% YoY).

🔄 What Changed
EBITDA grew 36% YoY to ₹209 crores, specialty chemicals contributed ₹100 crores (~15% of EBITDA), and CDMO pipeline expanded to 25 projects with INR1,500 crore peak revenue potential.

🔮 What's Next
INR750-800 crore EBITDA guidance for FY27; nutrition plant utilization to reach 70%+ by year-end; 5 new CDMO molecules added; lean savings target of ₹100 crores on track.

💡 Investor Takeaway
Strong top-line and margin expansion driven by specialty chemicals and nutrition, with scalable CDMO growth and improving utilization supporting sustained EBITDA momentum.

Jubilant Ingrevia reported ₹533 crores revenue in Q1 FY27, up 25% YoY, with net profit growing 41% to [amount context mismatch] crores. EBITDA surged 36% YoY to ₹209 crores, driven by specialty chemicals and nutrition segments contributing 70-80% of EBITDA. Chemical intermediates added ~15% to EBITDA at ₹100 crores. Management expects sequential EBITDA improvement to INR750-800 crores in FY27, with nutrition plant utilization targeting 70%+ by year-end. CDMO pipeline expanded to 25 projects with INR1,500 crore peak revenue potential, though estimates remain tentative. Confirmed CDMO molecules rose to 25, including 5 new additions. Specialty chemicals EBITDA margin held at 26%, supported by 95%+ pyridine utilization and captive consumption growth. Lean savings target of ₹100 crores remains on track. Safety awards and M&A integration (Remidex Pharma) underscore operational discipline. Investor Day scheduled at Bharuch facility.

📄 View Original Announcement (PDF)

📊 Stock Analysis — JUBLINGREA ✨ Ask AI About This

About Jubilant Ingrevia Limited (JUBLINGREA)

Chemicals · Chemicals · Listed on NSE

Market Cap: ₹10,740.33 Cr P/E: 34.5 ROE: 9.6% ROCE: 11.7% Div Yield: 0.37%

View full JUBLINGREA stock details →

📡 Get AI alerts when JUBLINGREA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track JUBLINGREA — Free

💡 Ask AI about this filing

"How will Q2 EBITDA guidance of INR28-odd crores compare to Q1's ₹209 crores?" "What is the expected timeline for CDMO contract volumes to materialize?" "How will rising power/fuel costs impact FY27 margin trajectory?"

Ask AI Free →

📊 More JUBLINGREA filings

See all JUBLINGREA filings →

🔥 Also filed on 27 July 2026

FAIRCHEMOR Fairchem Organics Limited Financial Results MPHASIS MphasiS Limited Insider Trading NTPC NTPC Limited Corporate Action CCL CCL Products (India) Limited Corporate Action ITI ITI Limited Announcement SHRIRAMFIN Shriram Finance Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when JUBLINGREA files new disclosures

Track JUBLINGREA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track JUBLINGREA — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd